The Osteoarthritis Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Osteoarthritis Therapeutics Market?
The global osteoarthritis therapeutics market has experienced significant growth recently. The market size is anticipated to increase from $8.17 billion in 2024 to $8.87 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Osteoarthritis Therapeutics Industry?
The osteoarthritis therapeutics global market is predicted to reach $12.22 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.3%.
Download Your Free Sample of the 2025 Osteoarthritis Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Osteoarthritis Therapeutics Market?
The key drivers in the osteoarthritis therapeutics market are:
• Rising obesity rates fueling osteoarthritis occurrence
• Advancements in treatment modalities for osteoarthritis
• Increasing awareness and diagnosis of osteoarthritis
• Development of disease-modifying osteoarthritis drugs (DMOADs) and funding for research.
Global Market Segmentation: Identifying Major Osteoarthritis Therapeutics Industry Segments
The osteoarthritis therapeuticsmarket covered in this report is segmented –
1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses
Pre-order the 2025 Osteoarthritis Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Osteoarthritis Therapeutics Market?
The key trends in the osteoarthritis therapeutics market are:
• Increasing focus on personalized medicine is shaping the future of osteoarthritis therapeutics.
• The emergence of regenerative therapies is gaining traction in the market.
• The expansion of pain management options is a significant emerging trend.
• Government and regulatory support along with rising demand in emerging markets are key trends.
Who Are the Top Competitors & Leading Players in the Osteoarthritis Therapeutics Market?
Major companies in the osteoarthritis therapeutics market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis AG
• GlaxoSmithKline plc
• Medtronic plc
• Eli Lilly and Company
• Gilead Sciences Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Daiichi Sankyo Company Limited
• Zimmer Biomet Holdings Inc.
• Horizon Therapeutics plc
• Taisho Pharmaceutical Co. Ltd.
• Ferring Pharmaceuticals
• Galapagos NV
• Bioventus LLC
• Flexion Therapeutics Inc.
• Anika Therapeutics Inc.
• Seikagaku Corporation
• Samumed LLC
• Orthogen AG
• Kolon Life Science Inc.
Regional Dominance: Which Area Leads the Global Osteoarthritis Therapeutics Market?
North America was the largest region in the osteoarthritis therapeutics market in 2022
